Stocks and Investing
Stocks and Investing
Fri, May 27, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mike Matson Upgraded (BSX) to Strong Buy and Held Target at $48 on, May 27th, 2022
Mike Matson of Needham, Upgraded "Boston Scientific Corporation" (BSX) to Strong Buy and Held Target at $48 on, May 27th, 2022.
Mike has made no other calls on BSX in the last 4 months.
There are 4 other peers that have a rating on BSX. Out of the 4 peers that are also analyzing BSX, 1 agrees with Mike's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $48 on, Thursday, April 28th, 2022
These are the ratings of the 3 analyists that currently disagree with Mike
- Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $47 on, Tuesday, May 17th, 2022
- Jayson Bedford of "Raymond James" Maintained at Strong Buy with Increased Target to $50 on, Thursday, April 28th, 2022
- Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Decreased Target to $51 on, Thursday, February 3rd, 2022
Contributing Sources